# In Vitro Investigations on the Antioxidant Effects of Vitamin D in a Panel of Cancer Cell Lines

**Authors:** Lina Elsalem, Farah A. Shobaki, Nosayba Al-Azzam, Abrar A. Aleikish, Haneen A. Basheer

PMC · DOI: 10.3390/biomedicines14020469 · Biomedicines · 2026-02-20

## TL;DR

This study shows that vitamin D reduces oxidative stress in various cancer cell lines, suggesting it may help prevent or treat certain cancers.

## Contribution

The study demonstrates vitamin D's antioxidant effects in multiple cancer types, highlighting its potential as a therapeutic agent.

## Key findings

- Vitamin D significantly reduced ROS levels in all cancer cell lines tested.
- Vitamin D increased SOD activity and protein expression across all cell lines.
- Antioxidant effects of vitamin D were dose-dependent and cell-type-specific.

## Abstract

Background: Oxidative stress plays a critical role in cancer initiation and progression. Although vitamin D exhibits multiple anti-tumorigenic properties, its antioxidant effects across different cancer types remain incompletely characterized. This study aimed to evaluate the antioxidant role of vitamin D in cancer. Methods: This in vitro study was conducted using breast (MCF-7, MDA-MB-231), colorectal (HCT-116, HT-29), and head and neck (Detroit-562, FaDu) cancer cell lines. Cells were treated with 1,25-dihydroxyvitamin D3 (1 nM, 10 nM, and 100 nM) for 48 h. Reactive oxygen species (ROS) were quantified using the ROS-Glo™ H2O2 assay. Oxidative stress biomarkers were assessed by measuring 8-hydroxy-2′-deoxyguanosine (8-OHdG) using enzyme-linked immunosorbent assay (ELISA), while thiobarbituric acid reactive substances (TBARS) and protein carbonyls (PC) were measured using colorimetric assays. Xanthine oxidase (XOD) protein levels were determined by ELISA, whereas superoxide dismutase (SOD) and catalase (CAT) activity and/or expression were evaluated using colorimetric assays. Results: Vitamin D significantly reduced ROS levels in all investigated cell lines in a dose-dependent manner compared with control cells (p < 0.05). Levels of 8-OHdG and TBARS were significantly decreased across all cell lines, whereas reductions in PC and XOD were cell-type-dependent. Vitamin D significantly increased SOD activity and protein expression in all cell lines, while CAT activity was elevated in most cell lines. Conclusions: This study provides proof-of-concept evidence that vitamin D exerts dose-dependent and cell-specific antioxidant effects in cancer. These findings suggest potential antioxidant roles for vitamin D in the prevention or treatment of breast, colorectal, and head and neck cancers.

## Linked entities

- **Proteins:** xod (xanthine oxidase), SOD1 (superoxide dismutase 1), CAT (catalase)
- **Chemicals:** 1,25-dihydroxyvitamin D3 (PubChem CID 5280453), 8-hydroxy-2′-deoxyguanosine (PubChem CID 135406132)
- **Diseases:** breast cancer (MONDO:0004989), colorectal cancer (MONDO:0005575), head and neck cancer (MONDO:0005627)

## Full-text entities

- **Genes:** CAT (catalase) [NCBI Gene 847], GPX3 (glutathione peroxidase 3) [NCBI Gene 2878] {aka GPx-P, GSHPx-3, GSHPx-P}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, VDR (vitamin D receptor) [NCBI Gene 486588], SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, PC (pyruvate carboxylase) [NCBI Gene 5091] {aka PCB}, POR (cytochrome p450 oxidoreductase) [NCBI Gene 5447] {aka CPR, CYPOR, P450R}, SOD2 (superoxide dismutase 2) [NCBI Gene 476258], TXNRD1 (thioredoxin reductase 1) [NCBI Gene 7296] {aka GRIM-12, TR, TR1, TRXR1, TXNR, TXNR1}, CAT (catalase) [NCBI Gene 403474], VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, JUND (JunD proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3727] {aka AP-1}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** PC (MESH:D011488), cardiovascular diseases (MESH:D002318), cytotoxic (MESH:D064420), metastasis (MESH:D009362), tumorigenic (MESH:D002471), breast and ovarian cancers (MESH:D061325), CRC (MESH:D015179), leukemia (MESH:D007938), bladder carcinoma (MESH:D001749), type 2 diabetes (MESH:D003924), breast and prostate cancers (MESH:D001943), ovarian cancer (MESH:D010051), lung cancer (MESH:D008175), diabetes mellitus (MESH:D003920), Cancer (MESH:D009369), HNC (MESH:D006258), injury to (MESH:D014947), inflammatory (MESH:D007249), osteosarcoma (MESH:D012516), bone cancer (MESH:D001859), neurological disorders (MESH:D009461), osteoarthritis (MESH:D010003), squamous cell carcinoma (MESH:D002294), low back pain (MESH:D017116), mammary tumor (MESH:D015674), gastric cancer (MESH:D013274), non-melanoma skin cancer (MESH:D012878), colorectal adenoma (MESH:D000236), vitamin D (MESH:D014808)
- **Chemicals:** amino acids (MESH:D000596), MDA (MESH:D008315), carbohydrates (MESH:D002241), ethyl acetate (MESH:C007650), H2O2 (MESH:D006861), F2-isoprostanes (MESH:D028441), superoxide (MESH:D013481), DMO412S (-), 1,25(OH)2D3 (MESH:D002117), TBARS (MESH:D017392), 1,25-dihydroxyvitamin D (MESH:C097949), ROS (MESH:D017382), calcium (MESH:D002118), CO2 (MESH:D002245), L-glutamine (MESH:D005973), Lipid (MESH:D008055), 2,4-dinitrophenylhydrazine (MESH:C004787), Vitamin D (MESH:D014807), essential amino acids (MESH:D000601), 4-HNE (MESH:C027576), ethanol (MESH:D000431), 8-OHdG (MESH:D000080242), aldehydes (MESH:D000447), tetrazolium salt (MESH:D013778), water (MESH:D014867), thiobarbituric acid (MESH:C029684)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Canis lupus familiaris (dog, subspecies) [taxon 9615]
- **Cell lines:** MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), Detroit-562 — Homo sapiens (Human), Pharyngeal squamous cell carcinoma, Cancer cell line (CVCL_1171), CCL-138 — Mus musculus (Mouse), Undefined cell line type (CVCL_M023), HTB-22 — Mus musculus (Mouse), Hybridoma (CVCL_A8FQ), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), HL60-G — Homo sapiens (Human), Adult acute myeloid leukemia with maturation, Cancer cell line (CVCL_0002), MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), MG-63 — Homo sapiens (Human), Osteosarcoma, Cancer cell line (CVCL_0426), FaDu — Homo sapiens (Human), Hypopharyngeal squamous cell carcinoma, Cancer cell line (CVCL_1218), HCT-116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938583/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938583/full.md

## References

64 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938583/full.md

---
Source: https://tomesphere.com/paper/PMC12938583